At Ketavita Wellness Clinic, we offer specialized treatments for obsessive-compulsive disorder that hasn’t responded adequately to traditional approaches. When standard medications and exposure-response prevention therapy haven’t provided sufficient relief, our IV ketamine, IM ketamine, and FDA-approved TMS therapy offer different mechanisms that target the underlying brain circuits involved in OCD.
Located in Wyckoff, New Jersey, our clinic provides evidence-based care from experienced medical professionals who understand how debilitating OCD can be. We create personalized treatment plans designed to help you achieve meaningful reduction in obsessions and compulsions, improving your quality of life and daily functioning.
Every treatment journey begins with a comprehensive evaluation where we review your OCD history, specific obsessions and compulsions, previous treatments tried, current symptom severity, and how OCD affects your daily life. We work closely with you throughout treatment, monitoring your response and adjusting protocols to optimize outcomes.
Obsessive-compulsive disorder is a chronic mental health condition characterized by persistent, intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) performed to reduce the anxiety caused by obsessions. OCD affects approximately 2-3% of the population and can significantly impair functioning when symptoms are severe.
Obsessions are unwanted, intrusive thoughts, images, or urges that cause significant distress or anxiety. Common obsessions include fears of contamination, concerns about harm coming to oneself or others, need for symmetry or exactness, forbidden or taboo thoughts, and intrusive aggressive or sexual thoughts. These obsessions are persistent and difficult to control or dismiss.
Compulsions are repetitive behaviors or mental acts performed in response to obsessions, aimed at reducing anxiety or preventing feared outcomes. Common compulsions include excessive washing or cleaning, repeated checking, counting or repeating actions, arranging items in specific ways, seeking reassurance, and mental rituals like counting or praying. While compulsions temporarily reduce anxiety, they maintain the OCD cycle by preventing natural anxiety reduction.
OCD exists on a spectrum from mild to severe. In severe cases, obsessions may be nearly constant and compulsions can consume hours each day, significantly interfering with work, relationships, and basic daily activities. The chronic nature of OCD and its resistance to treatment in many cases makes finding effective interventions critically important.
Treatment-resistant OCD occurs when you haven’t achieved adequate symptom control despite trying evidence-based first-line treatments. This typically means you’ve completed an adequate trial of at least one serotonin reuptake inhibitor at maximum tolerated dose for sufficient duration (typically 12 weeks), engaged in exposure and response prevention therapy with a qualified therapist, or tried combination treatment of medication plus ERP without satisfactory improvement.
Approximately 40-60% of people with OCD don’t achieve adequate symptom relief with first-line treatments. If you’ve tried multiple SRIs without success, found that ERP alone hasn’t provided sufficient benefit, experienced intolerable side effects from medications, or continue to have obsessions and compulsions that significantly impair your functioning despite treatment, you likely have treatment-resistant OCD.
Treatment resistance in OCD doesn’t mean your condition is untreatable—it means your OCD may require interventions targeting different neurobiological mechanisms. While standard OCD medications primarily work through serotonin systems, emerging research suggests glutamate neurotransmission plays an important role in OCD pathophysiology. Ketamine acts as an NMDA receptor antagonist affecting glutamate activity, offering a fundamentally different approach.
The persistent nature of treatment-resistant OCD can be exhausting and demoralizing. Ongoing obsessions and time-consuming compulsions restrict your life and affect relationships, work performance, and overall wellbeing. Specialized treatments like ketamine therapy provide new hope for meaningful symptom reduction when conventional approaches haven’t worked.
Ketavita Wellness Clinic specializes in advanced treatments for treatment-resistant obsessive-compulsive disorder:
IV Ketamine Therapy delivers ketamine through intravenous infusion over approximately 40 minutes. This method allows precise dosing and continuous monitoring throughout treatment. Research indicates ketamine can provide rapid anti-obsessional effects, with some patients experiencing symptom relief within hours to days rather than the 8-12 weeks typically required for SRI medications.
IM Ketamine Therapy provides ketamine through intramuscular injection, offering faster administration while delivering similar therapeutic benefits. This option eliminates IV placement and may be appropriate for certain patients based on individual factors and preferences.
TMS Therapy is FDA-approved as an adjunctive treatment for OCD in adults. This non-invasive treatment uses focused magnetic fields to stimulate brain regions involved in OCD circuits, including the supplementary motor area and prefrontal cortex. TMS doesn’t require medication or anesthesia, and many insurance plans cover treatment when medical necessity criteria are met. Treatment protocols for OCD typically include symptom provocation before each session to enhance therapeutic effects.
Ketamine works through NMDA receptor antagonism, modulating glutamate neurotransmission. TMS directly stimulates specific brain regions to normalize overactive circuits. Both approaches offer relief for treatment-resistant OCD through mechanisms different from conventional SRI medications. During your consultation, we’ll discuss which treatment may be most suitable for your specific situation and symptoms.
Ketamine therapy for OCD represents an off-label application, meaning it’s not FDA-approved specifically for obsessive-compulsive disorder. However, emerging research demonstrates potential efficacy for OCD symptoms, particularly in patients with near-constant obsessions who haven’t responded to conventional treatments.
Ketamine functions as a noncompetitive NMDA receptor antagonist, modulating glutamate neurotransmission in the brain. Converging evidence suggests glutamate abnormalities contribute to OCD pathophysiology, making glutamate-modulating agents like ketamine potential therapeutic options.
Brain imaging and neurochemical studies show that people with OCD have altered glutamate levels in specific brain regions involved in the disorder, including the orbitofrontal cortex, anterior cingulate cortex, and striatum. These areas form circuits that, when dysregulated, contribute to the persistent intrusive thoughts and repetitive behaviors characteristic of OCD.
By blocking NMDA receptors, ketamine rapidly increases glutamate signaling and promotes neuroplasticity—the formation of new neural connections. This may help reset disrupted brain patterns associated with OCD, potentially reducing both the frequency and intensity of obsessions and the urge to perform compulsions.
The rapid onset of ketamine’s anti-obsessional effects distinguishes it from conventional SRI medications.
While traditional OCD treatments require 8-12 weeks of daily use to achieve maximum benefit, ketamine research shows symptom improvement can occur within hours to days following administration. This quick action may be particularly valuable for individuals with severe, treatment-resistant OCD causing significant functional impairment.
Research also suggests ketamine’s effects may be enhanced when combined with exposure-based cognitive behavioral therapy, as the neuroplastic effects might facilitate extinction learning—the process by which ERP helps reduce anxiety responses to obsessional triggers.
Your OCD treatment journey at Ketavita begins with a thorough evaluation. We’ll discuss your OCD symptoms including specific obsessions you experience, compulsions you perform and how much time they consume, when symptoms began and how they’ve progressed, impact on your daily functioning and relationships, and any patterns or triggers you’ve identified.
We’ll also review your treatment history in detail: all medications tried with their doses and duration, your experience with exposure and response prevention therapy, response to each treatment attempt, and any side effects experienced. This comprehensive assessment helps us determine if ketamine therapy is appropriate for your OCD and develop the most effective treatment approach.
For IV ketamine therapy, treatment typically involves a series of infusions over several weeks. During each session, you’ll receive your ketamine infusion while resting in a private, comfortable treatment room. We monitor your vital signs continuously throughout the 40-minute infusion. You may experience mild dissociative effects during treatment—feelings of detachment or altered perception—but these are temporary and resolve within 1-2 hours.
For IM ketamine therapy, ketamine is administered as a simple intramuscular injection. The medication is absorbed through muscle tissue into the bloodstream. Administration takes only minutes, though you’ll still spend time in our office for observation after injection. Effects and monitoring procedures are similar to IV therapy.
After each treatment session, you’ll spend additional time in our office for recovery and monitoring before leaving. You cannot drive for 24 hours after ketamine treatment and must bring someone to drive you home. Most patients tolerate ketamine well, with common side effects including temporary dissociation, mild nausea, slight blood pressure elevation during infusion, and temporary dizziness.
Response to ketamine therapy for OCD varies among individuals. Research shows that some patients with near-constant obsessions experience rapid improvement within the first week following ketamine treatment. Others may require multiple sessions before achieving significant benefit. We use standardized OCD assessment tools like the Yale-Brown Obsessive Compulsive Scale to track your progress and adjust treatment based on your response.
Ketamine therapy for OCD may be appropriate if you’ve struggled with persistent symptoms despite conventional treatment attempts. You may be a candidate if you’ve tried at least one SRI medication at maximum tolerated dose for adequate duration without sufficient relief, completed or attempted exposure-response prevention therapy without adequate benefit, found that combination treatment of medication plus ERP hasn’t provided satisfactory symptom control, or continue to have obsessions and compulsions that significantly impair your functioning despite treatment.
Good candidates for ketamine therapy are adults with diagnosed OCD who remain significantly symptomatic despite appropriate trials of first-line treatments. Research suggests ketamine may be particularly effective for patients with near-constant intrusive thoughts, though more research is needed to identify which OCD presentations respond best.
Certain factors may affect treatment suitability. During evaluation, we review cardiovascular health (ketamine temporarily raises blood pressure), history of psychosis or other psychiatric conditions, substance use history, and any medications that might interact with ketamine. Your complete medical and psychiatric history helps ensure safe, appropriate treatment.
It’s important to understand that ketamine therapy for OCD represents an off-label use with a smaller evidence base compared to ketamine’s use for depression. While research demonstrates promising anti-obsessional effects, more large-scale studies are needed. We discuss these considerations transparently during consultation so you can make fully informed treatment decisions.
Our ketamine protocols for OCD are informed by emerging research demonstrating rapid anti-obsessional effects. Randomized controlled trials and systematic reviews show that ketamine can significantly reduce OCD symptom scores, with response rates of approximately 50% in patients with treatment-resistant OCD and near-constant obsessions.
Safety is paramount in all our treatments. Ketamine has been used safely in medical settings for decades, and we follow established safety protocols for subanesthetic dosing in psychiatric applications. All treatments are administered by licensed medical professionals with appropriate training, monitoring equipment, and emergency protocols.
We recognize that effective OCD management typically requires comprehensive treatment. While ketamine can provide rapid symptom relief, we strongly encourage continued engagement with exposure-response prevention therapy, appropriate medication management when indicated, and other evidence-based OCD interventions. Ketamine may be particularly effective when combined with intensive ERP, as the neuroplastic effects might facilitate therapeutic learning.
Patient education is essential to our approach. We ensure you understand how ketamine works differently from SRI medications, what the research shows about efficacy for OCD, realistic expectations given the current evidence base, and potential side effects or risks. Informed patients are better positioned to achieve optimal outcomes.
Ketamine therapy for OCD is typically not covered by insurance as it represents off-label use. We provide transparent pricing information during your consultation so you can make informed decisions about treatment.
IV ketamine therapy for OCD is $395 per session. A typical initial treatment series involves 6-8 infusions over 2-4 weeks, with maintenance sessions scheduled as needed based on symptom recurrence. The total investment depends on how many sessions you require and whether ongoing maintenance is necessary to maintain benefits.
We understand that cost is an important consideration, especially after already trying multiple treatments without success. However, many patients with treatment-resistant OCD find that even modest symptom reduction significantly improves their quality of life and functioning, justifying the investment.
While insurance typically doesn’t cover ketamine therapy for OCD, we can provide receipts and clinical documentation that you may submit to your insurance company for possible out-of-network reimbursement. Coverage decisions are made by individual insurance companies based on their policies.
If you’ve been struggling with obsessive-compulsive disorder despite trying conventional treatments, ketamine therapy at Ketavita Wellness Clinic may offer new hope. Our evidence-based approach provides rapid symptom relief through glutamate modulation that works differently than standard OCD medications.
Schedule a consultation to discuss your OCD history, explore whether ketamine therapy is appropriate for your situation, and develop a personalized treatment plan designed to help you reclaim your life from persistent obsessions and compulsions.
Living with treatment-resistant OCD is exhausting and isolating, but you don’t have to accept inadequate symptom control. Contact us today to learn how ketamine therapy can help you achieve the relief you’ve been seeking.
Research shows ketamine can produce significant OCD symptom reduction, with approximately 50% of patients with treatment-resistant OCD and near-constant obsessions meeting response criteria (≥35% symptom reduction) one week after a single ketamine infusion. However, the evidence base is still limited compared to ketamine’s use for depression.
Current research suggests ketamine may be particularly effective for reducing obsessions, especially in patients with near-constant intrusive thoughts. Effects on compulsions have been less consistently studied. During treatment, we’ll track both obsessions and compulsions to understand your specific response pattern.
Some patients experience rapid improvement in obsessions within hours to days after ketamine treatment. Research shows anti-obsessional effects can emerge during the infusion itself and persist for at least one week. However, response time varies among individuals.
Duration of benefit varies. Research indicates effects can persist for at least one week following a single infusion, with some patients maintaining improvement longer. Multiple infusions or maintenance sessions may be needed to sustain benefits. More research is needed on optimal dosing schedules for OCD.
Yes, in most cases. Many patients receive ketamine therapy while continuing their existing OCD medication regimen. We’ll review all your current medications during consultation to ensure there are no contraindications. Never discontinue medications without consulting your prescribing physician.
Emerging research suggests ketamine combined with exposure-based cognitive behavioral therapy may be more effective than ketamine alone. The neuroplastic effects of ketamine might enhance therapeutic learning during ERP. We encourage continued engagement with ERP therapy during and after ketamine treatment.
No. Ketamine is not a cure for OCD. It’s a treatment that can provide significant symptom relief, potentially allowing you to engage more effectively in ERP and other therapeutic approaches. OCD is a chronic condition typically requiring ongoing management.
The most common side effects are temporary and occur during or shortly after treatment: dissociative feelings, mild nausea, temporary blood pressure elevation, and dizziness. These effects typically resolve within 1-2 hours. Serious side effects are rare when ketamine is administered properly in medical settings.
Kwan ATH, Lakhani M, Singh G, et al. Ketamine for the treatment of psychiatric disorders: a systematic review and meta-analysis. CNS Spectrums. 2024. https://pubmed.ncbi.nlm.nih.gov/39564613/
de Sampaio Pereira Pedro M, Ferro A, Castelo Branco M, et al. Ketamine in the treatment of obsessive-compulsive disorder: a systematic review. Harvard Review of Psychiatry. 2022;30(2):135-145. https://pubmed.ncbi.nlm.nih.gov/35267254/
Mental Health Conditions
Conditions Treated
365 Franklin Avenue, Wyckoff, NJ 07481